Methotrexate, azathioprine, cyclosporine, and risk of fracture

Calcified Tissue International

Volumn 79, Issue 2, 2006, Pages 69-75

  Vestergaard, P ^a   Rejnmark, L ^a   Mosekilde, L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Azathioprine; Cyclosporine; Fracture risk; Methotrexate

Indexed keywords

ALCOHOL; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DIURETIC AGENT; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SEDATIVE AGENT;

ADULT; AGED; ALCOHOLISM; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; FEMALE; FOREARM FRACTURE; FRACTURE; HIP FRACTURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFORMATION RETRIEVAL; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; PSORIASIS; RANDOMIZATION; REGISTER; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SPINE FRACTURE; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS;

ADULT; AGED; AZATHIOPRINE; CASE-CONTROL STUDIES; CYCLOSPORINE; ENZYME INHIBITORS; FEMALE; FRACTURES, BONE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; REGISTRIES; RISK;

EID: 33748122879     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-006-0060-0     Document Type: Article

References (46)

1. Salmon SE (1987) Drugs and the immune system. In: Katzung BG (ed) Basic and Clinical Pharmacology Appleton & Lange, East Norwalk, CT, pp 702-718
2. Ferraccioli GF, Di Poi E, Damato R (2000) Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis. State of the art and perspectives. Clin Exp Rheumatol 18:S58-S60
3. Ferraccioli G, Salaffi F, De Vita S, et al. (1996) Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. J Rheumatol 23:624-628
4. Davies H, Olson L, Gibson P (2000) Methotrexate as a steroid sparing agent for asthma in adults. Cochrane Database Syst Rev CD000391
5. Lewis SJ, Ainslie GM, Bateman ED (1999) Efficacy of azathioprine as second-line treatment in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16:87-92
6. Vestergaard P, Rejnmark L, Mosekilde L (2005) Fracture risk associated with systemic and topical corticosteroids. J Intern Med 257:374-384
7. van Staa TP, Leufkens HGM, Abenhaim L, et al. (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993-1000
8. van Staa TP, Leufkens HGM, Cooper C (2001) Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res 16:581-588
9. van Staa TP, Laan RF, Barton IP, et al. (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224-3229
10. Herrala J, Puolijoki H, Impivaara O, et al. (1994) Bone mineral density in asthmatic women on high dose inhaled beclomethasone dipropionate. Bone 15:621-623
11. Laan RF, van Riel PL, van de Putte LB, et al. (1993) Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomised controlled study. Ann Intern Med 119:963-968
12. Wong CA, Walsh LJ, Smith CJ, et al. (2000) Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 355:1399-1403
13. Spiera RF, Mitnick HJ, Kupersmith M, et al. (2001) A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol 19:495-501
14. van Staa TP, Bishop N, Leufkens HG, et al. (2004) Are inhaled corticosteroids associated with an increased risk of fracture in children? Osteoporosis Int 15:785-791
15. Pfeilschifter J, Diel IJ (2000) Osteoporosis due to cancer treatment: pathogenesis and management. J Clin Oncol 18:1570-1593
16. van der Sluis I, van den Heuvel-Eibrink MM, Hahlen K, et al. (2000) Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 35:415-420
17. Friedlaender GE, Tross RB, Doganis AC, et al. (1984) Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (Adriamycin) treatment in a rat model. J Bone Joint Surg Am 66:602-607
18. Pelker RR, Friedlaender GE, Panjabi MM, et al. (1985) Chemotherapy-induced alterations in the biomechanics of rat bone. J Orthop Res 3:91-95
19. Gnudi S, Butturini L, Ripamonti C, et al. (1988) The effects of methotrexate (MTX) on bone. A densitometric study conducted on 59 patients with MTX administered at different doses. Ital J Orthop Traumatol 14:227-231
20. Buckley LM, Leib ES, Cartularo KS, et al. (1997) Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol 24:1489-1494
21. Carbone LD, Kaeley G, McKown KM, et al. (1999) Effects of long-term administration of methotrexate on bone mineral density in rheumatoid arthritis. Calcif Tissue Int 64:100-101
22. Cranney AB, McKendry RJ, Wells GA, et al. (2001) The effect of low dose methotrexate on bone density. J Rheumatol 28:2395-2399
23. Di Munno O, Mazzantini M, Sinigaglia L, et al. (2004) Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter crosssectional study. J Rheumatol 31:1305-1309
24. Mazzantini M, Di Munno O, Incerti-Vecchi L, et al. (2000) Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate. Clin Exp Rheumatol 18:327-331
25. Minaur NJ, Kounali D, Vedi S, et al. (2002) Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density. Rheumatology (Oxford) 41:741-749
26. Tascioglu F, Oner C, Armagan O (2003) The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis. Rheumatol Int 23:231-235
27. Ragab AH, Frech RS, Vietti TJ (1970) Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer 25:580-585
28. Stanisavljevic S, Babcock AL (1977) Fractures in children treated with methotrexate for leukemia. Clin Orthop Relat Res 125:139-144
29. Maenpaa HM, Soini I, Lehto MU, et al. (2002) Insufficiency fractures in patients with chronic inflammatory joint diseases. Clin Exp Rheumatol 20:77-79
30. Ferraccioli G, Casatta L, Bartoli E (1996) Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy. J Rheumatol 23:1539-1542
31. Aris RM, Neuringer IP, Weiner MA, et al. (1996) Severe osteoporosis before and after lung transplantation. Chest 109:1176-1183
32. Wacholder S, McLaughlin JK, Silverman DT, et al. (1992) Selection of controls in case-control studies. I. Principles. Am J Epidemiol 135:1019-1028
33. Vestergaard P, Emborg C, Støving RK, et al. (2002) Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders - a nation-wide register study. Int J Eat Disord 32:301-308
34. Vestergaard P, Rejnmark L, Mosekilde L (2004) Fracture risk associated with use of anti-epileptic drugs. Epilepsia 45:1330-1337
35. Rejnmark L, Vestergaard P, Mosekilde L (2005) Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 76:167-175
36. Rejnmark L, Vestergaard P, Mosekilde L (2006) Fracture risk in patients treated with loop diuretics. J Intern Med 259:117-124
37. Klotzbuecher CM, Ross PD, Landsman PB, et al. (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721-739
38. Kanis JA, Johansson H, Johnell O, et al. (2005) Alcohol intake as a risk factor for fracture. Osteoporosis Int 16:737-742
39. Andersen TF, Madsen M, Jørgensen J, et al. (1999) The Danish National Hospital Register. Dan Med Bull 46:263-268
40. Munk-Jørgensen P, Mortensen PB (1997) The Danish Psychiatric Central Register. Dan Med Bull 44:82-84
41. Mosbech J, Jørgensen J, Madsen M, et al. (1995) The Danish National Patient Register: evaluation of data quality [in Danish]. Ugeskr Læger 157:3741-3745
42. Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn's disease, and ulcerative colitis: a nation-wide follow-up study in 16,416 patients in Denmark. Am J Epidemiol 156:1-10
43. Zonneveld IM, Bakker WK, Dijkstra PF, et al. (1996) Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis. Arch Dermatol 132:184-187
44. Van Leeuwen BL, Kamps WA, Jansen HW, et al. (2000) The effect of chemotherapy on the growing skeleton. Cancer Treat Rev 26:363-376
45. Van Leeuwen BL, Verkerke GJ, Hartel RM, et al. (2003) Chemotherapy decreases epiphyseal strength and increases bone fracture risk. Clin Orthop Relat Res 413:243-254
46. Hoidrup S, Grønbæk M, Gottschau A, et al. (1999) Alcohol intake, beverage preference, and risk of hip fracture in men and women. Am J Epidemiol 149:993-1001